- €796.16m
- €1.53bn
- €2.45bn
- 90
- 79
- 53
- 89
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,754 | 1,534 | 1,842 | 2,226 | 2,446 |
Cost of Revenue | |||||
Gross Profit | 449 | 391 | 467 | 532 | 652 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,605 | 1,434 | 1,688 | 2,076 | 2,236 |
Operating Profit | 149 | 100 | 154 | 150 | 210 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 133 | 85.1 | 144 | 134 | 173 |
Provision for Income Taxes | |||||
Net Income After Taxes | 97.8 | 62.9 | 109 | 98.9 | 126 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 80 | 49.8 | 86.6 | 71.4 | 108 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 80 | 49.8 | 86.6 | 71.4 | 108 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.19 | 1.62 | 2.45 | 2.07 | 3.27 |
Dividends per Share |